Variant detail

SCN5AA1680T

c.5038G>A · residue 1680 · A → T
HGVS annotation

ClinVar-style identity and transcript context

ClinVar-style HGVS
NM_000335.5(SCN5A):c.5038G>A (A1680T)
HGVSc
c.5038G>A
cDNA change
c.5038G>A
RefSeq transcript
NM_000335.5
Ensembl transcript
ENST00000333535.9
Protein HGVS
A1680T
Genomic coordinate
NC_000003.12:g.38592825C>T
BrS1 penetrance Moderate risk
20% 90% credible interval 9–34%
0%20%50%100%

Emerging evidence · n=18 4 observed BrS1 carriers · 1.69 hypothetical affected and 8.31 hypothetical unaffected

LQT3 penetrance Low risk
5% 90% credible interval 0–13%
0%20%50%100%

Emerging evidence · n=18 1 observed LQT3 carriers · 0.0513 hypothetical affected and 4.95 hypothetical unaffected

One-sentence summary

Roughly 1 in 4 people who carry A1680T are estimated to eventually be diagnosed with Brugada syndrome — moderate penetrance, though evidence is limited (18 carriers). The residue lies in a Mild_Hotspot region for BrS1 and a Non_Hotspot region for LQT3.

Executive summary

Sources used for interpretation

The BrS1 and LQT3 penetrance estimates combine observed carrier counts with phenotype-specific feature-based model starting points. Other rows summarize supporting annotations for interpretation; not every row is a direct input to the model.

Estimatemodel output Observedmeasured in people/assays Model inputassumed, not observed Predictedcomputational Externalthird-party

Evidence

Carriers observed
18
4 BrS1 · 1 LQT3 · 13 unaffected
Model prior: BrS1 1.69 hypothetical affected / 8.31 hypothetical unaffected; LQT3 0.0513 hypothetical affected / 4.95 hypothetical unaffected
Emerging evidence
Functional data
Normal
9 published electrophysiology studies
Predictors and density
REVEL Likely damaging0.889range 0-1
PolyPhen-2 Probably damaging1range 0-1
BrS1 density Sparse region0.177range 0-1
LQT3 density Sparse region0.0199range 0-1
PROVEAN Deleterious-3.44cutoff <= -2.5
BLAST-PSSM -3.34lower = less tolerated
Range labels show the expected scale or cutoff. Calls are rough orientation from published cutoffs (hover a row) — not a clinical classification.

Automated ACMG/AMP review prompts

Generated from available data — not a clinical classification
PS3met · strong
Functional studies show damaging effect
PM1review
Hotspot or high BrS1/LQT3 density
PM2not met
Absent / extremely rare in population databases
PP3met · supporting
Multiple computational predictors support deleterious
BS1not met
Allele frequency too high for disorder
BP4not met
Computational predictors suggest no impact

Reported carrier data

Paper / cohort Carriers LQT3 / BrS1 Unaffected Other observations Variant context
Year 2006 · clinical carrier record
1 0 LQT3 0 1 other phenotype
Sudden adult death syndrome
Variant A1680T
Residue 1680
Curated carrier-count row
Year 2008 · clinical carrier record
2 0 LQT3
1 BrS1
0 1 other phenotype
SD
Variant A1680T
Residue 1680
Curated carrier-count row
Year 2009 · clinical carrier record
1 0 LQT3
1 BrS1
0 Not separately annotated
Variant A1680T
Residue 1680
Curated carrier-count row
Year 2013 · clinical carrier record
1 1 LQT3 0 Not separately annotated
Variant A1680T
Residue 1680
Curated carrier-count row
Year 2016 · clinical carrier record
1 0 LQT3 0 1 other phenotype
AF, BBB
Variant A1680T
Residue 1680
Curated carrier-count row
Year 2010 · clinical carrier record
1 0 LQT3
1 BrS1
0 Not separately annotated
Variant A1680T
Residue 1680
Curated carrier-count row
Year 2010 · clinical carrier record
1 0 LQT3
1 BrS1
0 Not separately annotated
Variant A1680T
Residue 1680
Curated carrier-count row
Year 2018 · clinical carrier record
1 0 LQT3
1 BrS1
0 Not separately annotated
Variant A1680T
Residue 1680
Curated carrier-count row
gnomAD population observations (v4) 13 0 LQT3
0 BrS1
13 Population observations; not known affected cases. gnomAD v4 allele count.
Hypothetical observations from model prior (not observed patients) 5 LQT3 prior;
10 BrS1 prior
0.0513 hypothetical LQT3 affected;
1.69 hypothetical BrS1 affected
4.95 hypothetical LQT3 unaffected;
8.31 hypothetical BrS1 unaffected
Phenotype-specific feature-based pseudo-counts added before observed carriers. Model input; not literature or gnomAD evidence.
Combined literature, cohort, and gnomAD 18 1 LQT3
4 BrS1
13 Combined totals used in the dual penetrance estimates. Curated carrier totals for this variant.

Model starting point. The BrS1 model starts with 1.69 hypothetical affected and 8.31 hypothetical unaffected observations; the LQT3 model starts with 0.0513 hypothetical affected and 4.95 hypothetical unaffected observations. Each then updates that starting point with the real carrier counts above. As observed carrier counts grow, these feature-based starting points have less influence.

Functional studies · researcher detail
PMIDYearCellPeak (%WT)V½ act (mV)V½ inact (mV)Late (%WT)
16712702 2006
18508782 2008
19564561 2009
23631430 2013
26746457 2016
20129283 2010
20129283 2010
30254039 2018
32533946 2020HEK 90-5.3-1.2
Structural neighbours · researcher detail

Residues within 15 Å of A1680T; observed variants link to their detail pages.

NeighbourDistance (Å)Observed variants
17417.8 D1741N, D1741Y, D1741E, D1741E,
130414.9 T1304M,
168714.7
169813.8 A1698T,
174513.5
167311.9
16758.0
17438.7 G1743R, G1743R, G1743E,
16814.5 c.5040_5042delTTAinsC, Y1681F,
16946.8
12268.1
174711.7 V1747M,
171613.7 p.L1716SfsX71,
16956.0 Q1695X,
168811.3
168412.2 W1684R, W1684R,
16767.0 M1676T, M1676I, M1676I, M1676I,
169214.1
17449.7 S1744I,
172113.7
167211.5 S1672Y,
17429.2
16938.5
169911.7
173812.9 S1738T, S1738F,
16800.0 A1680T, A1680P,
170313.2
171911.8
173113.6
122811.8 Y1228H, Y1228C, Y1228F,
169012.0 c.5068_5070delGA, D1690N,
16787.3 N1678S,
122314.5 c.3667delG,
169713.5
123013.9 E1230K,
12277.0
130012.5
167411.7 F1674V,
122912.6
174812.9 p.G1748del, G1748D
16839.4
130112.5
16969.9
168914.6 D1689N,
173910.7 R1739W, R1739Q,
170011.2
171715.0 L1717P,
173414.1
175113.0
16776.7
16825.2
175214.9
172214.5 N1722D,
17406.9 G1740R, G1740R,
122511.9 E1225K, G1225K,
169114.6
172010.1 c.5157delC,
173211.3
16795.6
168513.7
View this variant elsewhere